rs370862426
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2
The NM_001103.4(ACTN2):c.2108A>T(p.Gln703Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000743 in 1,614,214 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001103.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACTN2 | NM_001103.4 | c.2108A>T | p.Gln703Leu | missense_variant | Exon 17 of 21 | ENST00000366578.6 | NP_001094.1 | |
ACTN2 | NM_001278343.2 | c.2108A>T | p.Gln703Leu | missense_variant | Exon 17 of 21 | NP_001265272.1 | ||
ACTN2 | NR_184402.1 | n.2480A>T | non_coding_transcript_exon_variant | Exon 19 of 23 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251352Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135848
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461886Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727244
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152328Hom.: 0 Cov.: 32 AF XY: 0.0000805 AC XY: 6AN XY: 74492
ClinVar
Submissions by phenotype
not provided Uncertain:2
Identified in a family with HCM who also harbored a pathogenic variant in the MYBPC3 gene (LIN Lirong et al., 2021); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function -
- -
not specified Uncertain:1
The p.Gln703Leu variant in ACTN2 has not been previously reported in individuals with cardiomyopathy, but has been identified in 4/8644 East Asian chromosomes b y the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs370862426). Computational prediction tools and conservation analysis suggest t hat the p.Gln703Leu variant may impact the protein, though this information is n ot predictive enough to determine pathogenicity. In summary, the clinical signif icance of the p.Gln703Leu variant is uncertain. -
Cardiovascular phenotype Uncertain:1
The p.Q703L variant (also known as c.2108A>T), located in coding exon 17 of the ACTN2 gene, results from an A to T substitution at nucleotide position 2108. The glutamine at codon 703 is replaced by leucine, an amino acid with dissimilar properties. This alteration has been reported in a dilated cardiomyopathy (DCM) cohort (Lian H et al. J Transl Med, 2023 Jul;21:476). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. -
Cardiomyopathy Benign:1
- -
Primary familial hypertrophic cardiomyopathy;C2677338:Dilated cardiomyopathy 1AA Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at